OraSure Technologies Revenue 2006-2019 | OSUR
OraSure Technologies revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| OraSure Technologies Annual Revenue (Millions of US $) |
|
|---|---|
| 2018 | $182 |
| 2017 | $167 |
| 2016 | $128 |
| 2015 | $120 |
| 2014 | $106 |
| 2013 | $99 |
| 2012 | $88 |
| 2011 | $82 |
| 2010 | $75 |
| 2009 | $77 |
| 2008 | $71 |
| 2007 | $83 |
| 2006 | $68 |
| 2005 | $69 |
| OraSure Technologies Quarterly Revenue (Millions of US $) |
|
|---|---|
| Q3 2019 | $36 |
| Q2 2019 | $39 |
| Q1 2019 | $30 |
| Q4 2018 | $50 |
| Q3 2018 | $46 |
| Q2 2018 | $44 |
| Q1 2018 | $42 |
| Q4 2017 | $52 |
| Q3 2017 | $42 |
| Q2 2017 | $40 |
| Q1 2017 | $33 |
| Q4 2016 | $35 |
| Q3 2016 | $32 |
| Q2 2016 | $31 |
| Q1 2016 | $29 |
| Q4 2015 | $32 |
| Q3 2015 | $30 |
| Q2 2015 | $30 |
| Q1 2015 | $27 |
| Q4 2014 | $29 |
| Q3 2014 | $28 |
| Q2 2014 | $26 |
| Q1 2014 | $24 |
| Q4 2013 | $29 |
| Q3 2013 | $25 |
| Q2 2013 | $24 |
| Q1 2013 | $21 |
| Q4 2012 | $22 |
| Q3 2012 | $22 |
| Q2 2012 | $23 |
| Q1 2012 | $21 |
| Q4 2011 | $24 |
| Q3 2011 | $22 |
| Q2 2011 | $19 |
| Q1 2011 | $17 |
| Q4 2010 | $19 |
| Q3 2010 | $19 |
| Q2 2010 | $19 |
| Q1 2010 | $18 |
| Q4 2009 | $21 |
| Q3 2009 | $22 |
| Q2 2009 | $17 |
| Q1 2009 | $17 |
| Q4 2008 | $17 |
| Q3 2008 | $17 |
| Q2 2008 | $19 |
| Q1 2008 | $18 |
| Q4 2007 | $20 |
| Q3 2007 | $21 |
| Q2 2007 | $21 |
| Q1 2007 | $20 |
| Q4 2006 | $18 |
| Q3 2006 | $18 |
| Q2 2006 | $18 |
| Q1 2006 | $15 |
| Q4 2005 | $18 |
| Q3 2005 | $18 |
| Q2 2005 | $17 |
| Q1 2005 | $16 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.492B | $0.182B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $151.583B | 20.94 |
| Abbott Laboratories (ABT) | United States | $151.168B | 27.57 |
| Stryker (SYK) | United States | $76.313B | 25.66 |
| Boston Scientific (BSX) | United States | $61.440B | 29.00 |
| Baxter (BAX) | United States | $42.463B | 25.75 |
| Essilor Luxottica (ESLOY) | France | $33.468B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $30.550B | 19.17 |
| Terumo (TRUMY) | Japan | $27.062B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.531B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.294B | 39.03 |
| ResMed (RMD) | United States | $21.653B | 39.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.279B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $19.151B | 0.00 |
| Insulet (PODD) | United States | $11.373B | 541.06 |
| Bio-Rad Laboratories (BIO) | United States | $11.201B | 53.76 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.616B | 0.00 |
| William Demant Holdings (WILYY) | Denmark | $7.531B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.203B | 21.24 |
| Perrigo (PRGO) | Ireland | $7.117B | 13.27 |
| Canopy Growth (CGC) | Canada | $6.501B | 0.00 |
| Haemonetics (HAE) | United States | $6.146B | 41.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.743B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.276B | 0.00 |
| NuVasive (NUVA) | United States | $3.890B | 30.64 |
| ICU Medical (ICUI) | United States | $3.830B | 24.97 |
| Neogen (NEOG) | United States | $3.545B | 59.33 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.165B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.121B | 0.00 |
| Quidel (QDEL) | United States | $2.954B | 28.04 |
| Aurora Cannabis (ACB) | Canada | $2.648B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.432B | 54.89 |
| Agios Pharmaceuticals (AGIO) | United States | $2.411B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.577B | 0.00 |
| InMode (INMD) | Israel | $1.516B | 0.00 |
| AtriCure (ATRC) | United States | $1.226B | 0.00 |
| Aphria (APHA) | $1.187B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.162B | 23.28 |
| Phibro Animal Health (PAHC) | United States | $0.994B | 18.61 |
| NanoString Technologies (NSTG) | United States | $0.944B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.802B | 20.04 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.771B | 29.55 |
| TG Therapeutics (TGTX) | United States | $0.709B | 0.00 |
| Quanterix (QTRX) | United States | $0.705B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.698B | 39.25 |
| PetIQ (PETQ) | United States | $0.675B | 16.46 |
| Omeros (OMER) | United States | $0.655B | 0.00 |
| Cerus (CERS) | United States | $0.574B | 0.00 |
| Surmodics (SRDX) | United States | $0.570B | 59.24 |
| HEXO (HEXO) | $0.537B | 0.00 | |
| Owens & Minor (OMI) | United States | $0.474B | 17.53 |
| MacroGenics (MGNX) | United States | $0.474B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.405B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.396B | 28.71 |
| Meridian Bioscience (VIVO) | United States | $0.396B | 13.62 |
| BioLife Solutions (BLFS) | United States | $0.331B | 134.92 |
| Zynex (ZYXI) | United States | $0.329B | 37.22 |
| Bovie Medical (APYX) | United States | $0.275B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.269B | 0.00 |
| United Health Products (UEEC) | United States | $0.249B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.242B | 25.52 |
| Vapotherm (VAPO) | United States | $0.227B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.195B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.192B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.164B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.153B | 773.00 |
| Chimerix (CMRX) | United States | $0.151B | 0.00 |
| Female Health (VERU) | United States | $0.148B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.141B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.128B | 9.03 |
| MTech Acquisition (KERN) | United States | $0.114B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 23.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.080B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.069B | 0.00 |
| Nephros (NEPH) | United States | $0.064B | 0.00 |
| Surface Oncology (SURF) | United States | $0.062B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| Senestech (SNES) | United States | $0.017B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.015B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.013B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.012B | 0.00 |
| Myomo (MYO) | United States | $0.008B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
